Using Self-Replicating RNA Technology to Treat Telomere Biology Disorders with Akihiro Ko Elixirgen Therapeutics TRANSCRIPT
Download PDFFeb 2, 2023
Akihiro Ko is the CEO and Co-Founder of Elixirgen Therapeutics, which was founded with the mission of treating patients using RNA technology. Their c-srRNA, controllable self-replicating RNA, technology is being applied to telomere biology disorders where patients have inherited short telomeres and a failure to develop...
Feb 2, 2023
Akihiro Ko is the CEO and Co-Founder of Elixirgen Therapeutics, which was founded with the mission of treating patients using RNA technology. Their c-srRNA, controllable self-replicating RNA, technology is being applied to telomere biology disorders where patients have inherited short telomeres and a failure to develop...
Aggregating and Curating Healthcare Data to Address Infectious Diseases and Public Health with Dr. Richard Parker Arcadia TRANSCRIPT
Download PDFFeb 1, 2023
Rich Parker, MD Chief Medical Officer at Arcadia, is working with large healthcare providers to provide data analytics to address the needs of large populations of patients and very specific groups facing unique challenges. The goal is to get the signal-to-noise ratio correct as quickly as possible to, for example,...
Feb 1, 2023
Rich Parker, MD Chief Medical Officer at Arcadia, is working with large healthcare providers to provide data analytics to address the needs of large populations of patients and very specific groups facing unique challenges. The goal is to get the signal-to-noise ratio correct as quickly as possible to, for example,...
Jan 31, 2023
Tuvik Beker, CEO of Pangea Biomed, is looking for more accurate biomarkers for oncology to determine better who might benefit from a specific drug. Their ENLIGHT platform is a pan-cancer, pan-treatment response predictor and can be used to find the best patient populations to give a new drug. They are also working with...